Fixval Suspention 100mg-5ml 30ml

The bactericidal action of Cefixime is due to the inhibition of cell wall synthesis. It binds to one of the penicillin binding proteins (PBPs) which inhibits the final transpeptidation step of the peptidoglycan synthesis in the bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death.

Absorption Only 40–50% is absorbed from the GI tract (oral bioavailability). Absorption may be decreased when taken with food. Average peak concentration after administration of oral suspension is approximately 25–50% greater than the peak concentration following oral tablet or capsules administration.

Distribution It has high concentrations in bile and urine. It can cross the placenta and its protein binding capacity is 65%.

Fixval Suspention 100mg-5ml 30ml treats infections of the Uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli and Proteus mirabilis. Otitis media caused by Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes. Tonsillitis and pharyngitis caused by Streptococcus pyogenes.

Fixval Suspention 100mg-5ml 30ml treats chronic bronchitis caused by Streptococcus pneumoniae and Haemophilus influenzae.

Fixval Suspention 100mg-5ml 30ml treats gonorrhea (cervical/urethral) caused by susceptible isolates of Neisseria gonorrhoeae (penicillinase-and non-penicillinase-producing isolates). It is also used to treat typhoid fever.